Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 27-Jun-18 7:52 PM View:  | Outlook Therapeutics, Inc. (OTLK) | 25-Jun-18 | Market Sale | 7,700 | $0.85 | $6,507.27 | (14%) 54.82K to 47.12K | 75% |
| 26-Dec-17 5:06 PM View: | Outlook Therapeutics, Inc. (OTLK) | 22-Dec-17 | Market Sale | 26,165 | $1.13 | $29,566.40 | 91% 28.66K to 54.82K | (82%) |
| 22-Dec-16 6:00 PM View: | Outlook Therapeutics, Inc. (OTLK) | 21-Dec-16 | Grant | 50,000 | -- | -- | 161% 30.98K to 80.98K | |
| 17-May-16 8:36 PM View: | Outlook Therapeutics, Inc. (OTLK) | 13-May-16 | Purchase | 2,000 | -- | -- | 100% 0 to 2.0K | |
| 17-Oct-13 11:20 AM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 16-Oct-13 | Market Sale | 8,000 | $0.07 | $589.25 | (7%) 108.0K to 100.0K | 19% |
| 17-Oct-13 11:20 AM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 15-Oct-13 | Market Sale | 70,211 | $0.08 | $5,712.13 | (39%) 178.21K to 108.0K | 29% |
| 01-May-13 5:37 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 30-Apr-13 | Market Sale (Planned) | 1,250 | $0.74 | $925.00 | (< 1%) 179.46K to 178.21K | 24% |
| 06-Feb-13 10:19 AM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 04-Feb-13 | Market Sale (Planned) | 29,000 | $1.03 | $29,941.00 | (14%) 200.75K to 171.75K | 46% |
| 04-Feb-13 1:57 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 31-Jan-13 | Market Sale (Planned) | 1,300 | $1.03 | $1,339.00 | (< 1%) 202.05K to 200.75K | 46% |
| 06-Nov-12 6:39 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 31-Oct-12 | Market Sale (Planned) | 1,000 | $1.45 | $1,450.00 | (< 1%) 203.05K to 202.05K | 61% |
| 03-Aug-12 8:38 AM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 01-Aug-12 | Market Sale (Planned) | 4,950 | $0.62 | $3,069.00 | (2%) 208.0K to 203.05K | 8% |
| 13-Feb-12 6:36 AM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 01-Feb-12 | Grant | 150,000 | $2.26 | $339,000.00 | 259% 58.0K to 208.0K | (75%) |
| 18-Nov-11 4:13 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 16-Nov-11 | Market Purchase | 5,000 | $2.59 | $12,945.00 | 9% 53.0K to 58.0K | (78%) |
| 16-Sep-11 7:05 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 14-Sep-11 | Market Purchase | 2,500 | $3.95 | $9,871.25 | 2% 102.5K to 105.0K | (86%) |
| 16-Sep-11 7:05 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 14-Sep-11 | Market Purchase | 500 | $3.97 | $1,982.75 | < 1% 105.0K to 105.5K | (86%) |
| 02-Aug-11 4:17 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 31-Jul-11 | Grant | 50,000 | $7.00 | $350,000.00 | (50%) 100.0K to 50.0K | 92% |